Tag: Prostate cancer

Prostate cancer once looked simple. It isn't. Science now knows there are at least 15 distinct cell lines, a single tumor can harbor multiple, and each patient's cancer behaves differently. Genomic biomarker tests are changing how doctors navigate that complexity, defining risk more precisely and helping tailor treatment to the individual. keep reading

"You have prostate cancer." Those words hit hard — and immediately, every part of you wants it gone. At Sperling Prostate Center, we understand that. We treat both the tumor and the man behind it, balancing advanced focal therapy with attention to lifestyle, values, and what matters most to each patient. keep reading

What if treating prostate cancer didn't mean choosing between all-or-nothing surgery and a watchful waiting approach that leaves many men anxious? Focal therapy has emerged as a precision middle ground — and a new journal review offers the most thorough look yet at how it works, what it achieves, and which men are the best candidates. keep reading

Most men with radiation-recurrent prostate cancer once had few good options — hormone therapy delayed the disease but offered no hope of cure. Today, focal salvage ablation is changing that picture. Now, a global expert panel has outlined the clinical trial standards needed to put this promising treatment on solid scientific footing. keep reading

In a murder mystery, the killer is often hiding in plain sight. The same can happen with prostate cancer. In 10-15% of cases that appear low risk, hidden aggressive disease is waiting for an unexpected twist. A deeper diagnostic workup—mpMRI, genomic analysis, and other tools—can reveal the true nature of the disease before a treatment plan is locked in. keep reading

Less than a third of men with a PSA result in the "gray zone" of 4–10 actually have prostate cancer. Yet for years, that number alone sent patients straight to biopsy. Today, mpMRI offers a smarter first step and a newly FDA-approved blood test called IsoPSA may be the safety net for cases MRI can't fully resolve. keep reading

Half of all men will deal with prostatitis at some point. The problem? Its symptoms — pelvic pain, urinary trouble, elevated PSA — can look almost identical to prostate cancer on standard tests. Before rushing to a biopsy, there's a better path: 3T multiparametric MRI can tell the difference with high accuracy and no needles required. keep reading

Your gut is home to trillions of bacteria that do far more than help with digestion. New research suggests an imbalanced gut microbiome, driven by diet, may quietly raise prostate cancer risk through inflammation and immune system disruption. keep reading

Smoking raises prostate cancer risk by 40–60% — most men know that. But what about the air outside your door? A Canadian study found that two common pollutants, PM2.5 and nitrogen dioxide, are linked to higher PCa risk even in men who've never smoked. And a 2025 European report warns a far broader chemical threat is quietly building. keep reading

Prostate cancer patients benefit from personalized exercise plans, including resistance training, aerobic activity, and high-intensity intervals. Each type of exercise brings unique advantages—supporting strength, cardiovascular health, recovery, and overall well-being. keep reading